MarketCapTrends
AYTU

Aytu BioPharma Inc. (AYTU)

NASDAQ · Healthcare

Aytu BioPharma Inc. annual/quarterly shareholder equity history from 2014 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Aytu BioPharma Inc. shareholder equity for the quarter ending June 30, 2025 were 19.0M, a 31.57% decrease year-over-year.
  • Aytu BioPharma Inc. shareholder equity for 2025 were 19.0M, a 31.57% decrease from 2024.
  • Aytu BioPharma Inc. shareholder equity for 2024 were 27.7M, a 29.58% decrease from 2023.
  • Aytu BioPharma Inc. shareholder equity for 2023 were 39.4M, a 11.17% decrease from 2022.
  • Aytu BioPharma Inc. shareholder equity for 2022 were 44.3M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Aytu BioPharma Inc. Annual Shareholder Equity (Millions of US $)
2025$19
2024$28
2023$39
2022$44
2021$138
2020$95
2019$7
2018$13
2017$4
2016$10
2015$16
2014$5
Aytu BioPharma Inc. Quarterly Shareholder Equity (Millions of US $)
2025-06-30$19
2024-06-30$28
2023-06-30$39
2022-06-30$44
2021-06-30$138
2020-06-30$95
2019-06-30$7
2018-06-30$13
2017-06-30$4
2016-06-30$10
2015-06-30$16
2014-06-30$5

Aytu BioPharma Inc. Shareholder Equity — FAQ

Aytu BioPharma Inc. (AYTU) shareholder equity over the last 12 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see AYTU's shareholder equity history?

The chart and table above show Aytu BioPharma Inc.'s shareholder equity by year and by quarter, including the growth rate.